RhoVac AB announced that the board has decided to appoint board member Lars Hedbys as acting CEO of RhoVac, starting from September 1, 2022. As previously announced, Anders Månsson submitted his resignation on 15 July and will take up his new position on 1 September.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 SEK | +51.43% | -.--% | -6.03% |
04-30 | Chosa Oncology AB Announces Resignation of Lars Hedbys as Chairman | CI |
03-28 | Chosa Oncology Names CFO, Chief Commercial Officer | MT |
1st Jan change | Capi. | |
---|---|---|
-6.03% | 3.17M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- CHOSA Stock
- News Chosa Oncology AB
- RhoVac AB Appoints Lars Hedbys as Acting CEO, Starting from September 1, 2022